Summit Therapeutics
SMMT
#1541
Rank
S$18.25 B
Marketcap
S$22.83
Share price
9.25%
Change (1 day)
-4.13%
Change (1 year)

Summit Therapeutics (SMMT) - Total assets

Total assets on the balance sheet as of June 2026 : S$0.96 Billion

According to Summit Therapeutics 's latest financial reports the company's total assets are S$0.96 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Summit Therapeutics - Total assets on balance sheet (from 2020 to 2020)

Total assets by year

Year Total assets Change
2023-12-31S$0.26 B-69.9%
2022-12-31S$0.89 B480.92%
2021-12-31S$0.15 B13.03%
2020-12-31S$0.13 B
2019-01-31S$0.14 B-3.15%
2018-01-31S$0.14 B73.86%
2017-01-31S$83.4 M15.21%
2016-01-31S$72.39 M21.29%
2015-01-31S$59.68 M135.89%
2014-01-31S$25.3 M87.46%
2013-01-31S$13.49 M11.72%
2012-01-31S$12.08 M-26.41%
2011-01-31S$16.41 M-60.23%
2010-01-31S$41.27 M-4.15%
2009-01-31S$43.06 M-78%
2008-01-31S$0.19 B39.76%
2007-01-31S$0.14 B87.48%
2006-01-31S$74.69 M-9.87%
2005-01-31S$82.86 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sarepta Therapeutics
SRPT
S$4.08 B 323.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$0.31 B-67.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
S$0.24 B-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA